Method of predicting glaucoma conversion proves to be faster
Increased access is key to preventing disease progression in patients.
Dropless glaucoma treatment an elusive path to ease burden
Physicians are left to determine which treatments can offer patients best outcomes.
MIGS and cataract surgery option offers positive results
Retrospective review highlights the sustained efficacy of combination procedure.
Investigators start pivotal subretinal gene therapy trial
RGX-314 eyed by investigators as a therapeutic option for exudative AMD.
Examining stability of aspheric IOL in cataract patients
Bi-sign design compensates for aberrations resulting from misalignment.
The use of MIGS trends and patterns in the US
Use of such procedures increased markedly in analysis of IRIS Registry Data.
Snapshot: Managing endogenous endophthalmitis in patients
UK physician notes a full systemic work-up needed to determine source of infection.
Retinal nonperfusion, leakage linked with center-involved DME
Study results show that aflibercept-treated eyes are protected.
Fluocinolone acetonide implant safe for chronic uveitis treatment
Study results show the device offers an effective long-term option for patients.
New options are on horizon for presbyopia-correcting drops
Therapeutic choices beneficial for patients may be available in 1 to 3 years.
Big Brother is watching: Technology is looking out for me
A word from Chief Medical Editor Peter J. McDonnell, MD.
Reading glasses denial
Check out the latest cartoon!
Advantages of incorporating ECP into the surgeon’s armamentarium
Short learning curve, significant clinical advantages make this a comfortable addition.
Shedding light on Horner syndrome
Clues to dangerous etiologies include pain and positive imaging findings.
